Biopharmaceutical CMO & CRO Market by Source, Service Type and Application - Global Industry Analysis & Forecast to 2027
Published On : May 2022 Pages : 154 Category: Biotechnology Report Code : HC053577
Biopharmaceutical CMO & CRO Market by Source (Non-mammalian, Mammalian) Service Type (Contract Research, Contract Manufacturing) Application (Biosimilars, Biologics) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Biopharmaceutical CMO & CRO Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. A contract manufacturing organization (CMO), sometimes called contract development and manufacturing organization (CDMO), is an organization that serves different organizations in the pharmaceutical business on a contract premise to give exhaustive administrations from medication advancement through medication producing. A contract research organization (CRO) is an association that offers help to the pharmaceutical, biotechnology, and restorative gadget enterprises as research administrations outsourced on a contract premise.
Drivers and Restraints
Rising interest in biopharmaceutical industry by the noticeable members to upgrade their profitability and effectiveness has driven the biomanufacturers to build their attention on re-appropriating exercises. As of now, biopharma organizations have started re-appropriating the asset and capital-escalated steps and in few cases, the whole chain of biomanufacturing, consequently boosting interest for contract based administrations. Mergers and acquisitions help CMOs offer coordinated bioprocessing administrations to their customers, which, thusly, makes CMOs/CROs an appealing and achievable alternative for the quick product dispatch.
Regional Insights
Asia Pacific biopharmaceutical CMO and CRO market is expected to enlist the quickest CAGR amid the figure forecast period.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Inno Biologics Sdn Bhd
- Rentschler Biotechnologie SE
- Lonza
- JRS PHARMA
- BIOMEVA GmbH
- Boehringer Ingelheim GmbH
- Samsung BioLogics
- CELONIC AG
- FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
- ProBioGen AG
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Biopharmaceutical CMO & CRO Market, By Source, Estimates and Forecast, 2017-2027 ($Million)
o Non-mammalian
o Mammalian
· Biopharmaceutical CMO & CRO Market, By Service Type, Estimates and Forecast, 2017-2027 ($Million)
o Contract Research
o Contract Manufacturing
· Biopharmaceutical CMO & CRO Market, By Product, Estimates and Forecast, 2017-2027 ($Million)
o Biosimilars
o Biologics
· Biopharmaceutical CMO & CRO Market, By Key Players
o Inno Biologics Sdn Bhd
o Rentschler Biotechnologie SE
o Lonza
o JRS PHARMA
o BIOMEVA GmbH
o Boehringer Ingelheim GmbH
o Samsung BioLogics
o CELONIC AG
o FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
o ProBioGen AG
· Biopharmaceutical CMO & CRO Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Biopharmaceutical CMO & CRO Market, By Country
o U.S. Biopharmaceutical CMO & CRO Market
o Canada Biopharmaceutical CMO & CRO Market
o Mexico Biopharmaceutical CMO & CRO Market
o Europe
§ Europe Biopharmaceutical CMO & CRO Market, By Country
o Germany Biopharmaceutical CMO & CRO Market
o UK Biopharmaceutical CMO & CRO Market
o France Biopharmaceutical CMO & CRO Market
o Russia Biopharmaceutical CMO & CRO Market
o Italy Biopharmaceutical CMO & CRO Market
o Rest of Europe Biopharmaceutical CMO & CRO Market
o Asia-Pacific
§ Asia-Pacific Biopharmaceutical CMO & CRO Market, By Country
o China Biopharmaceutical CMO & CRO Market
o Japan Biopharmaceutical CMO & CRO Market
o South Korea Biopharmaceutical CMO & CRO Market
o India Biopharmaceutical CMO & CRO Market
o Southeast Asia Biopharmaceutical CMO & CRO Market
o Rest of Asia-Pacific Biopharmaceutical CMO & CRO Market
o South America
§ South America Biopharmaceutical CMO & CRO Market
o Brazil Biopharmaceutical CMO & CRO Market
o Argentina Biopharmaceutical CMO & CRO Market
o Columbia Biopharmaceutical CMO & CRO Market
o Rest of South America Biopharmaceutical CMO & CRO Market
o Middle East and Africa
§ Middle East and Africa Biopharmaceutical CMO & CRO Market
o Saudi Arabia Biopharmaceutical CMO & CRO Market
o UAE Biopharmaceutical CMO & CRO Market
o Egypt Biopharmaceutical CMO & CRO Market
o Nigeria Biopharmaceutical CMO & CRO Market
o South Africa Biopharmaceutical CMO & CRO Market
o Rest of MEA Biopharmaceutical CMO & CRO Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. SWOT Analysis
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Biopharmaceutical CMO And CRO Market, By Source
5.1. Introduction
5.2. Global Biopharmaceutical CMO And CRO Revenue and Market Share by Source (2017-2027)
5.2.1. Global Biopharmaceutical CMO And CRO Revenue and Revenue Share by Source (2017-2027)
5.3. Non-mammalian
5.3.1. Global Non-mammalian Revenue and Growth Rate (2017-2027)
5.4. Mammalian
5.4.1. Global Mammalian Revenue and Growth Rate (2017-2027)
6. Biopharmaceutical CMO And CRO Market, By Service Type
6.1. Introduction
6.2. Global Biopharmaceutical CMO And CRO Revenue and Market Share by Service Type (2017-2027)
6.2.1. Global Biopharmaceutical CMO And CRO Revenue and Revenue Share by Service Type (2017-2027)
6.3. Contract Research
6.3.1. Global Contract Research Revenue and Growth Rate (2017-2027)
6.4. Contract Manufacturing
6.4.1. Global Contract Manufacturing Revenue and Growth Rate (2017-2027)
7. Biopharmaceutical CMO And CRO Market, By Product
7.1. Introduction
7.2. Global Biopharmaceutical CMO And CRO Revenue and Market Share by Product (2017-2027)
7.2.1. Global Biopharmaceutical CMO And CRO Revenue and Revenue Share by Product (2017-2027)
7.3. Biosimilars
7.3.1. Global Biosimilars Revenue and Growth Rate (2017-2027)
7.4. Biologics
7.4.1. Global Biologics Revenue and Growth Rate (2017-2027)
8. Biopharmaceutical CMO And CRO Market, By Region
8.1. Introduction
8.2. Global Biopharmaceutical CMO And CRO Revenue and Market Share by Regions
8.2.1. Global Biopharmaceutical CMO And CRO Revenue by Regions (2017-2027)
8.3. North America Biopharmaceutical CMO And CRO by Countries
8.3.1. North America Biopharmaceutical CMO And CRO Revenue and Growth Rate (2017-2027)
8.3.2. North America Biopharmaceutical CMO And CRO Revenue (Million USD) by Countries (2017-2027)
8.3.3. United States
8.3.3.1. United States Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.4. Canada
8.3.4.1. Canada Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.5. Mexico
8.3.5.1. Mexico Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe Biopharmaceutical CMO And CRO by Countries
8.4.1. Europe Biopharmaceutical CMO And CRO Revenue and Growth Rate (2017-2027)
8.4.2. Europe Biopharmaceutical CMO And CRO Revenue (Million USD) by Countries (2017-2027)
8.4.3. Germany
8.4.3.1. Germany Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.4. France
8.4.4.1. France Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.5. UK
8.4.5.1. UK Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. Russia
8.4.6.1. Russia Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. Italy
8.4.7.1. Italy Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Rest of Europe
8.4.8.1. Rest of Europe Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific Biopharmaceutical CMO And CRO by Countries
8.5.1. Asia-Pacific Biopharmaceutical CMO And CRO Revenue and Growth Rate (2017-2027)
8.5.2. Asia-Pacific Biopharmaceutical CMO And CRO Revenue (Million USD) by Countries (2017-2027)
8.5.3. China
8.5.3.1. China Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.4. Japan
8.5.4.1. Japan Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.5. Korea
8.5.5.1. Korea Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6. India
8.5.6.1. India Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.7. Southeast Asia
8.5.7.1. Southeast Asia Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. Rest of Asia-Pacific
8.5.8.1. Rest of Asia-Pacific Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America Biopharmaceutical CMO And CRO by Countries
8.6.1. South America Biopharmaceutical CMO And CRO Revenue and Growth Rate (2017-2027)
8.6.2. South America Biopharmaceutical CMO And CRO Revenue (Million USD) by Countries (2017-2027)
8.6.3. Brazil
8.6.3.1. Brazil Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.4. Argentina
8.6.4.1. Argentina Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.5. Columbia
8.6.5.1. Columbia Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Rest of South America
8.6.6.1. Rest of South America Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa Biopharmaceutical CMO And CRO by Countries
8.7.1. Middle East and Africa Biopharmaceutical CMO And CRO Revenue and Growth Rate (2017-2027)
8.7.2. Middle East and Africa Biopharmaceutical CMO And CRO Revenue (Million USD) by Countries (2017-2027)
8.7.3. Saudi Arabia
8.7.3.1. Saudi Arabia Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.4. United Arab Emirates
8.7.4.1. United Arab Emirates Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.5. Egypt
8.7.5.1. Egypt Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. Nigeria
8.7.6.1. Nigeria Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. South Africa
8.7.7.1. South Africa Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. Turkey
8.7.8.1. Turkey Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. Rest of Middle East and Africa
8.7.9.1. Rest of Middle East and Africa Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2027)
9. Company Profiles
9.1. Inno Biologics Sdn Bhd
9.1.1. Business Overview
9.1.2. Service Portfolio
9.1.3. Strategic Developments
9.1.4. Financial Overview
9.2. Rentschler Biotechnologie SE
9.2.1. Business Overview
9.2.2. Service Portfolio
9.2.3. Strategic Developments
9.2.4. Financial Overview
9.3. Lonza
9.3.1. Business Overview
9.3.2. Service Portfolio
9.3.3. Strategic Developments
9.3.4. Financial Overview
9.4. JRS PHARMA
9.4.1. Business Overview
9.4.2. Service Portfolio
9.4.3. Strategic Developments
9.4.4. Financial Overview
9.5. BIOMEVA GmbH
9.5.1. Business Overview
9.5.2. Service Portfolio
9.5.3. Strategic Developments
9.5.4. Financial Overview
9.6. Boehringer Ingelheim GmbH
9.6.1. Business Overview
9.6.2. Service Portfolio
9.6.3. Strategic Developments
9.6.4. Financial Overview
9.7. Samsung BioLogics
9.7.1. Business Overview
9.7.2. Service Portfolio
9.7.3. Strategic Developments
9.7.4. Financial Overview
9.8. CELONIC AG
9.8.1. Business Overview
9.8.2. Service Portfolio
9.8.3. Strategic Developments
9.8.4. Financial Overview
9.9. FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
9.9.1. Business Overview
9.9.2. Service Portfolio
9.9.3. Strategic Developments
9.9.4. Financial Overview
9.10. ProBioGen AG
9.10.1. Business Overview
9.10.2. Service Portfolio
9.10.3. Strategic Developments
9.10.4. Financial Overview
10. Global Biopharmaceutical CMO And CRO Market Competition, by Manufacturer
10.1. Global Biopharmaceutical CMO And CRO Financial Overview by Manufacturer (2017-2017)
10.2. Global Biopharmaceutical CMO And CRO Price By Region (2017-2017)
10.3. Top 5 Biopharmaceutical CMO And CRO Manufacturer Market Share
10.4. Market Competition Trend
11. Biopharmaceutical CMO And CRO Market Forecast (2017-2027)
11.1. Global Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2027)
11.2. Biopharmaceutical CMO And CRO Market Forecast by Regions (2017-2027)
11.2.1. North America Biopharmaceutical CMO And CRO Market Forecast (2017-2027)
11.2.1.1. United States Biopharmaceutical CMO And CRO Market Forecast (2017-2027)
11.2.1.2. Canada Biopharmaceutical CMO And CRO Market Forecast (2017-2027)
11.2.1.3. Mexico Biopharmaceutical CMO And CRO Market Forecast (2017-2027)
11.2.2. Europe Biopharmaceutical CMO And CRO Market Forecast (2017-2027)
11.2.2.1. Germany Biopharmaceutical CMO And CRO Market Forecast (2017-2027)
11.2.2.2. France Biopharmaceutical CMO And CRO Market Forecast (2017-2027)
11.2.2.3. UK Biopharmaceutical CMO And CRO Market Forecast (2017-2027)
11.2.2.4. Russia Biopharmaceutical CMO And CRO Market Forecast (2017-2027)
11.2.2.5. Italy Biopharmaceutical CMO And CRO Market Forecast (2017-2027)
11.2.2.6. Rest of Europe Biopharmaceutical CMO And CRO Market Forecast (2017-2027)
11.2.3. Asia-Pacific Biopharmaceutical CMO And CRO Market Forecast (2017-2027)
11.2.3.1. China Biopharmaceutical CMO And CRO Market Forecast (2017-2027)
11.2.3.2. Japan Biopharmaceutical CMO And CRO Market Forecast (2017-2027)
11.2.3.3. Korea Biopharmaceutical CMO And CRO Market Forecast (2017-2027)
11.2.3.4. India Biopharmaceutical CMO And CRO Market Forecast (2017-2027)
11.2.3.5. Southeast Asia Biopharmaceutical CMO And CRO Market Forecast (2017-2027)
11.2.3.6. Rest of Asia-Pacific Biopharmaceutical CMO And CRO Market Forecast (2017-2027)
11.2.4. South America Biopharmaceutical CMO And CRO Market Forecast (2017-2027)
11.2.4.1. Brazil Biopharmaceutical CMO And CRO Market Forecast (2017-2027)
11.2.4.2. Argentina Biopharmaceutical CMO And CRO Market Forecast (2017-2027)
11.2.4.3. Columbia Biopharmaceutical CMO And CRO Market Forecast (2017-2027)
11.2.4.4. Rest of South America Biopharmaceutical CMO And CRO Market Forecast (2017-2027)
11.2.5. Middle East and Africa Biopharmaceutical CMO And CRO Market Forecast (2017-2027)
11.2.5.1. Saudi Arabia Biopharmaceutical CMO And CRO Market Forecast (2017-2027)
11.2.5.2. United Arab Emirates Biopharmaceutical CMO And CRO Market Forecast (2017-2027)
11.2.5.3. Egypt Biopharmaceutical CMO And CRO Market Forecast (2017-2027)
11.2.5.4. Nigeria Biopharmaceutical CMO And CRO Market Forecast (2017-2027)
11.2.5.5. South Africa Biopharmaceutical CMO And CRO Market Forecast (2017-2027)
11.2.5.6. Turkey Biopharmaceutical CMO And CRO Market Forecast (2017-2027)
11.2.5.7. Rest of Middle East and Africa Biopharmaceutical CMO And CRO Market Forecast (2017-2027)
11.3. Biopharmaceutical CMO And CRO Market Forecast by Source (2017-2027)
11.3.1. Biopharmaceutical CMO And CRO Forecast by Source (2017-2027)
11.3.2. Biopharmaceutical CMO And CRO Market Share Forecast by Source (2017-2027)
11.4. Biopharmaceutical CMO And CRO Market Forecast by Service Type (2017-2027)
11.4.1. Biopharmaceutical CMO And CRO Forecast by Service Type (2017-2027)
11.4.2. Biopharmaceutical CMO And CRO Market Share Forecast by Service Type (2017-2027)
11.5. Biopharmaceutical CMO And CRO Market Forecast by Product (2017-2027)
11.5.1. Biopharmaceutical CMO And CRO Forecast by Product (2017-2027)
11.5.2. Biopharmaceutical CMO And CRO Market Share Forecast by Product (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Biopharmaceutical CMO And CRO Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Biopharmaceutical CMO And CRO Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Biopharmaceutical CMO And CRO Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Biopharmaceutical CMO And CRO Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Biopharmaceutical CMO And CRO Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Biopharmaceutical CMO And CRO Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Biopharmaceutical CMO And CRO Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Biopharmaceutical CMO And CRO Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Biopharmaceutical CMO And CRO Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Biopharmaceutical CMO And CRO Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Biopharmaceutical CMO And CRO Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Biopharmaceutical CMO And CRO Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Biopharmaceutical CMO And CRO Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Biopharmaceutical CMO And CRO Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Biopharmaceutical CMO And CRO Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Biopharmaceutical CMO And CRO Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Biopharmaceutical CMO And CRO Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Biopharmaceutical CMO And CRO Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Biopharmaceutical CMO And CRO Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Biopharmaceutical CMO And CRO Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Biopharmaceutical CMO And CRO Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Biopharmaceutical CMO And CRO Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Biopharmaceutical CMO And CRO Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Biopharmaceutical CMO And CRO Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Biopharmaceutical CMO And CRO Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Biopharmaceutical CMO And CRO Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Biopharmaceutical CMO And CRO Revenue and Revenue Share by Source (2017-2018)
Figure Global Non-mammalian Revenue and Growth Rate (2017-2018)
Figure Global Mammalian Revenue and Growth Rate (2017-2018)
Table Global Biopharmaceutical CMO And CRO Revenue and Revenue Share by Service Type (2017-2018)
Figure Global Contract Research Revenue and Growth Rate (2017-2018)
Figure Global Contract Manufacturing Revenue and Growth Rate (2017-2018)
Table Global Biopharmaceutical CMO And CRO Revenue and Revenue Share by Product (2017-2018)
Figure Global Biosimilars Revenue and Growth Rate (2017-2018)
Figure Global Biologics Revenue and Growth Rate (2017-2018)
Table Global Biopharmaceutical CMO And CRO Revenue by Regions (2017-2018)
Figure North America Biopharmaceutical CMO And CRO Growth Rate (2017-2018)
Figure North America Biopharmaceutical CMO And CRO Revenue and Growth Rate (2017-2018)
Figure North America Biopharmaceutical CMO And CRO by Countries (2017-2018)
Figure North America Biopharmaceutical CMO And CRO Revenue (Million USD) by Countries (2017-2018)
Figure United States Biopharmaceutical CMO And CRO Growth Rate (2017-2018)
Figure United States Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Biopharmaceutical CMO And CRO Growth Rate (2017-2018)
Figure Canada Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Biopharmaceutical CMO And CRO Growth Rate (2017-2018)
Figure Mexico Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Biopharmaceutical CMO And CRO Growth Rate (2017-2018)
Figure Europe Biopharmaceutical CMO And CRO Revenue and Growth Rate (2017-2018)
Figure Europe Biopharmaceutical CMO And CRO by Countries (2017-2018)
Figure Europe Biopharmaceutical CMO And CRO Revenue (Million USD) by Countries (2017-2018)
Figure Germany Biopharmaceutical CMO And CRO Growth Rate (2017-2018)
Figure Germany Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Biopharmaceutical CMO And CRO Growth Rate (2017-2018)
Figure France Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Biopharmaceutical CMO And CRO Growth Rate (2017-2018)
Figure UK Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Biopharmaceutical CMO And CRO Growth Rate (2017-2018)
Figure Russia Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Biopharmaceutical CMO And CRO Growth Rate (2017-2018)
Figure Italy Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Biopharmaceutical CMO And CRO Growth Rate (2017-2018)
Figure Rest of Europe Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Biopharmaceutical CMO And CRO Growth Rate (2017-2018)
Figure Asia-Pacific Biopharmaceutical CMO And CRO Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Biopharmaceutical CMO And CRO by Countries (2017-2018)
Figure Asia-Pacific Biopharmaceutical CMO And CRO Revenue (Million USD) by Countries (2017-2018)
Figure China Biopharmaceutical CMO And CRO Growth Rate (2017-2018)
Figure China Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Biopharmaceutical CMO And CRO Growth Rate (2017-2018)
Figure Japan Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Biopharmaceutical CMO And CRO Growth Rate (2017-2018)
Figure Korea Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Biopharmaceutical CMO And CRO Growth Rate (2017-2018)
Figure India Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Biopharmaceutical CMO And CRO Growth Rate (2017-2018)
Figure Southeast Asia Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Biopharmaceutical CMO And CRO Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Biopharmaceutical CMO And CRO Growth Rate (2017-2018)
Figure South America Biopharmaceutical CMO And CRO Revenue and Growth Rate (2017-2018)
Figure South America Biopharmaceutical CMO And CRO by Countries (2017-2018)
Figure South America Biopharmaceutical CMO And CRO Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Biopharmaceutical CMO And CRO Growth Rate (2017-2018)
Figure Brazil Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Biopharmaceutical CMO And CRO Growth Rate (2017-2018)
Figure Argentina Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Biopharmaceutical CMO And CRO Growth Rate (2017-2018)
Figure Columbia Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Biopharmaceutical CMO And CRO Growth Rate (2017-2018)
Figure Rest of South America Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Biopharmaceutical CMO And CRO Growth Rate (2017-2018)
Figure Middle East and Africa Biopharmaceutical CMO And CRO Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Biopharmaceutical CMO And CRO by Countries (2017-2018)
Figure Middle East and Africa Biopharmaceutical CMO And CRO Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Biopharmaceutical CMO And CRO Growth Rate (2017-2018)
Figure Saudi Arabia Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Biopharmaceutical CMO And CRO Growth Rate (2017-2018)
Figure United Arab Emirates Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Biopharmaceutical CMO And CRO Growth Rate (2017-2018)
Figure Egypt Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Biopharmaceutical CMO And CRO Growth Rate (2017-2018)
Figure Nigeria Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Biopharmaceutical CMO And CRO Growth Rate (2017-2018)
Figure South Africa Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Biopharmaceutical CMO And CRO Growth Rate (2017-2018)
Figure Turkey Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Biopharmaceutical CMO And CRO Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2017-2018)
Table Inno Biologics Sdn Bhd Biopharmaceutical CMO And CRO Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Rentschler Biotechnologie SE Biopharmaceutical CMO And CRO Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Lonza Biopharmaceutical CMO And CRO Price, Revenue, Gross Margin and Market Share (2017-2017)
Table JRS PHARMA Biopharmaceutical CMO And CRO Price, Revenue, Gross Margin and Market Share (2017-2017)
Table BIOMEVA GmbH Biopharmaceutical CMO And CRO Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Boehringer Ingelheim GmbH Biopharmaceutical CMO And CRO Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Samsung BioLogics Biopharmaceutical CMO And CRO Price, Revenue, Gross Margin and Market Share (2017-2017)
Table CELONIC AG Biopharmaceutical CMO And CRO Price, Revenue, Gross Margin and Market Share (2017-2017)
Table FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biopharmaceutical CMO And CRO Price, Revenue, Gross Margin and Market Share (2017-2017)
Table ProBioGen AG Biopharmaceutical CMO And CRO Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Biopharmaceutical CMO And CRO Market Share by Manufacturer
Figure Global Biopharmaceutical CMO And CRO Revenue and Market Share by Manufacturer
Table Global Biopharmaceutical CMO And CRO Price by Region (2017-2017)
Figure Top 5 Biopharmaceutical CMO And CRO Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Biopharmaceutical CMO And CRO Revenue (Millions USD) and Growth Rate (2018-2025)
Table Biopharmaceutical CMO And CRO Market Forecast by Regions (2018-2025)
Figure North America Biopharmaceutical CMO And CRO Market Forecast (2018-2025)
Figure United States Biopharmaceutical CMO And CRO Market Forecast (2018-2025)
Figure Canada Biopharmaceutical CMO And CRO Market Forecast (2018-2025)
Figure Mexico Biopharmaceutical CMO And CRO Market Forecast (2018-2025)
Figure Europe Biopharmaceutical CMO And CRO Market Forecast (2018-2025)
Figure Germany Biopharmaceutical CMO And CRO Market Forecast (2018-2025)
Figure France Biopharmaceutical CMO And CRO Market Forecast (2018-2025)
Figure UK Biopharmaceutical CMO And CRO Market Forecast (2018-2025)
Figure Russia Biopharmaceutical CMO And CRO Market Forecast (2018-2025)
Figure Italy Biopharmaceutical CMO And CRO Market Forecast (2018-2025)
Figure Rest of Europe Biopharmaceutical CMO And CRO Market Forecast (2018-2025)
Figure Asia-Pacific Biopharmaceutical CMO And CRO Market Forecast (2018-2025)
Figure China Biopharmaceutical CMO And CRO Market Forecast (2018-2025)
Figure Japan Biopharmaceutical CMO And CRO Market Forecast (2018-2025)
Figure Korea Biopharmaceutical CMO And CRO Market Forecast (2018-2025)
Figure India Biopharmaceutical CMO And CRO Market Forecast (2018-2025)
Figure Southeast Asia Biopharmaceutical CMO And CRO Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Biopharmaceutical CMO And CRO Market Forecast (2018-2025)
Figure South America Biopharmaceutical CMO And CRO Market Forecast (2018-2025)
Figure Brazil Biopharmaceutical CMO And CRO Market Forecast (2018-2025)
Figure Argentina Biopharmaceutical CMO And CRO Market Forecast (2018-2025)
Figure Columbia Biopharmaceutical CMO And CRO Market Forecast (2018-2025)
Figure Rest of South America Biopharmaceutical CMO And CRO Market Forecast (2018-2025)
Figure Middle East and Africa Biopharmaceutical CMO And CRO Market Forecast (2018-2025)
Figure Saudi Arabia Biopharmaceutical CMO And CRO Market Forecast (2018-2025)
Figure United Arab Emirates Biopharmaceutical CMO And CRO Market Forecast (2018-2025)
Figure Egypt Biopharmaceutical CMO And CRO Market Forecast (2018-2025)
Figure Nigeria Biopharmaceutical CMO And CRO Market Forecast (2018-2025)
Figure South Africa Biopharmaceutical CMO And CRO Market Forecast (2018-2025)
Figure Turkey Biopharmaceutical CMO And CRO Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Biopharmaceutical CMO And CRO Market Forecast (2018-2025)
Figure Global Biopharmaceutical CMO And CRO Forecast by Source (2018-2025)
Figure Global Biopharmaceutical CMO And CRO Market Share Forecast by Source (2018-2025)
Figure Global Biopharmaceutical CMO And CRO Forecast by Source (2018-2025)
Figure Global Biopharmaceutical CMO And CRO Forecast by Service Type (2018-2025)
Figure Global Biopharmaceutical CMO And CRO Market Share Forecast by Service Type (2018-2025)
Figure Global Biopharmaceutical CMO And CRO Forecast by Service Type (2018-2025)
Figure Global Biopharmaceutical CMO And CRO Forecast by Product (2018-2025)
Figure Global Biopharmaceutical CMO And CRO Market Share Forecast by Product (2018-2025)
Figure Global Biopharmaceutical CMO And CRO Forecast by Product (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|